tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Mathew Blackman - 35 which are a Hold (37.23%), 58 which are a Buy (61.7%), 1 which are a Sell (1.06%)
Analyst Mathew Blackman works at STIFEL and is covering the Healthcare sector with 192 price targets and ratings displayed on 16 stocks.
Mathew Blackman's average stock forecast success ratio is 68.5% with an average time for price targets to be met of 158 days.
Most recent stock forecast was given on GMED, Globus Medical at 19-Sep-2023.
Analyst best performing recommendations are on DXCM (DEXCOM).
The best stock recommendation documented was for DXCM (DEXCOM) at 10/23/2019. The price target of $47.5 was fulfilled within 15 days with a profit of $10.88 (29.71%) receiving and performance score of 19.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
21
$12.22 (139.18%)
20
2 months 15 days ago
1/12 (8.33%)
$8.04 (49.68%)
15
Buy
18
$9.22 (105.01%)
29
4 months 17 days ago
0/3 (0%)
$7.6 (52.67%)
Buy
11
$2.22 (25.28%)
40
4 months 18 days ago
6/7 (85.71%)
$3.81 (16.63%)
36
Buy
11.3
$2.52 (28.70%)
28
4 months 18 days ago
6/12 (50%)
$6.48 (30.49%)
56
Buy
17
$8.22 (93.62%)
22
4 months 18 days ago
4/12 (33.33%)
$9.53 (43.50%)
55
Which stock is Mathew Blackman is most bullish on?
Which stock is Mathew Blackman is most reserved on?
What Year was the first public recommendation made by Mathew Blackman?
